Microbial Genetic Expression, Regulation, and Chemotherapeutics

Biological Information and Nucleic Acid Structure

• Nature of Biological Information:

  • Biological information is defined as the instruction set required to build and maintain an organism.

  • Information is fundamental and independent of the physical medium upon which it is stored or encoded. In biological systems, nucleic acids serve as the physical substrate for storage and transmission.

• Nucleic Acid Monomers and Molecular Components:

  • Bases: Nitrogenous heterocyclic bases consisting of purines and pyrimidines.

  • Nucleosides: Composed of a nitrogenous base covalently linked to a pentose sugar (ribose in RNA or 2'-deoxyribose in DNA).

  • Nucleotides: Composed of a nucleoside bound to one or more phosphate groups (Base + Sugar + Phosphate). Nucleotides serve as the fundamental monomeric units of nucleic acid polymers.

  • Example chemical structure: Deoxyadenylic acid (deoxyadenosine 5'-monophosphate), containing adenine bound to carbon 1' ($\text{C}(1')$) of deoxyribose, and a phosphate group bound to carbon 5' ($\text{C}(5')$).

• Purines vs. Pyrimidines:

  • Purines: Two-ring fused structures; larger molecules.

  • Adenine (A)

  • Guanine (G)

• Pyrimidines: Single-ring structures; smaller molecules.

  • Cytosine (C)

  • Uracil (U) (found in RNA)

  • Thymine (T) (found in DNA)

  • Complementarity and Information Capacity of DNA Strands:

• Double-stranded DNA consists of two antiparallel polynucleotide chains held together by hydrogen bonds between complementary base pairs.

• Adenine pairs specifically with Thymine (via two hydrogen bonds), and Guanine pairs with Cytosine (via three hydrogen bonds).

• Because of strict complementary base pairing rules, both strands of a double-stranded DNA molecule contain the exact same amount of biological information. Knowing the nucleotide sequence of one strand allows full reconstruction of the partner strand.

• Example sequence complementarity:

  • $5'\text{-A-T-C-C-T-G-G-A-}3'$

  • $3'\text{-T-A-G-G-A-C-C-T-}5'$

Evolutionary Refinement of the Central Dogma

• Historical 1950s Model (Classical Central Dogma):

  • Formulated as a simple linear flow of genetic information: DNA undergoes self-replication ($\text{DNA} \rightarrow \text{DNA}$), DNA is transcribed into RNA ($\text{DNA} \rightarrow \text{RNA}$), and RNA is translated into functional protein ($\text{RNA} \rightarrow \text{Protein}$).

• Intermediate Regulatory Model:

  • Incorporated reverse transcription ($\text{RNA} \rightarrow \text{DNA}$) driven by viral retrotranscriptases.

  • Identified pre-mRNA processing pathways including splicing and alternative splicing, allowing single gene units to produce multiple distinct polypeptide isoforms.

  • Recognized post-translational protein modifications, including phosphorylation, glycosylation, methylation, and acetylation.

• Modern Central Dogma Network:

  • Incorporates multidirectional regulation and epigenetic mechanisms:

  • DNA Modifications & Epigenetics: Histone modifications, direct DNA methylation, and non-coding epigenetic markers influence transcription rates without changing the underlying nucleotide sequence.

  • Non-Coding and Catalytic RNAs: MicroRNAs (miRNAs), short interfering RNAs (siRNAs), and other catalytic or regulatory RNAs regulate mRNA stability and translation efficiency.

  • Protein Complexity: Expands post-translational processing to include RNA editing, conformational isomers (prions), glycosylation, phosphorylation, methylation, acetylation, and ubiquitin-mediated proteolytic target pathways.

DNA Architecture and Packaging in Bacteria

• Physical Dimensions and Supercoiling:

  • The genome of Escherichia coli consists of a single circular double-stranded DNA molecule.

  • The unfolded circular chromosome is approximately $1500 \times$ the total length of the bacterial cell.

• Nucleoid Structure:

  • To fit within the cytoplasm without a membrane-bound nucleus, DNA is condensed into a highly organized structure known as the nucleoid.

  • The chromosome is organized into multiple independent loops.

  • Loops are held in place and anchored by specialized nucleoid-associated proteins.

  • Each individual loop contains tightly supercoiled DNA, regulated by topoisomerases, which allows localized unwinding without disrupting the global compaction of the entire chromosome.

Mechanism and Dynamics of DNA Replication

• Experimental Proof of Semiconservative Replication (Meselson and Stahl):

  • Three theoretical modes of DNA replication were proposed: Conservative, Semiconservative, and Dispersive.

  • Meselson and Stahl cultured E. coli in heavy isotope isotope media (${}^{15}\text{N}$) for multiple generations (heavy/heavy $\text{H/H}$ DNA), then transferred cells to light isotope media (${}^{14}\text{N}$) to observe density gradient centrifugation profiles across subsequent generations.

  • Generation 1: Produced a single intermediate-density band ($\text{H/L}$), ruling out the conservative model (which predicted separate $\text{H/H}$ and $\text{L/L}$ bands).

  • Generation 2: Produced two distinct bands of equal intensity: one intermediate ($\text{H/L}$) and one light ($\text{L/L}$), ruling out the dispersive model (which predicted a single progressively lightening hybrid band).

  • Generations 3 and 4: The light band ($\text{L/L}$) became progressively dominant while the intermediate band ($\text{H/L}$) persisted at a constant low concentration, definitively proving semiconservative replication.

• Initiation at $oriC$:

  • Chromosomal replication begins at a unique, designated origin sequence termed $oriC$

  • Specialized loader proteins place DNA Helicase complexes onto both ends of the opened origin region.

  • Replication proceeds bi-directionally around the circular bacterial chromosome, creating two expanding replication forks that move in opposite directions until meeting at the terminus region.

• Replication Fork Machinery and Steps:

  • DNA Helicase: Unwinds and melts double-stranded DNA at the fork, generating single-stranded templates.

  • Primase (DnaG): Recruited directly by helicase. DNA polymerases cannot initiate synthesis de novo and require a free $3'\text{-OH}$ group. Primase synthesizes short RNA primers ($\sim 10\text{--}12$ nucleotides) complementary to single-stranded DNA to provide this initial $3'\text{-OH}$.

  • Clamp Loader and Sliding Clamp ($\beta$-clamp): The clamp loader complex uses ATP to load the homodimeric sliding clamp onto the RNA primer site. The sliding clamp tethers DNA Polymerase III to the template strand, enabling high processivity.

  • DNA Polymerase III: The primary replicative enzyme. Synthesizes new DNA strictly in the $5' \rightarrow 3'$ direction. The chemical energy driving the reaction originates from the cleavage of high-energy pyrophosphate ($\text{PP}_i$) from incoming nucleoside triphosphates (dNTPs).

• Asymmetric Synthesis: Leading vs. Lagging Strands:

  • Leading Strand: Synthesized continuously in the $5' \rightarrow 3'$ direction, following the forward movement of DNA helicase. Requires only a single initial RNA primer.

  • Lagging Strand: Synthesized discontinuously in the direction opposite to fork movement.

  • As helicase unwinds DNA, primase periodically lays down new RNA primers.

  • DNA Polymerase III extends from each primer until it reaches the previously synthesized segment, creating short DNA segments termed Okazaki fragments (approximately $1000$ base pairs long in bacteria).

• Maturation of Okazaki Fragments and Ligase Action:

  • RNase H: Specific endoribonuclease that recognizes RNA-DNA hybrids and degrades the RNA primers present on leading and lagging strands.

  • DNA Polymerase I: Binds the single-stranded gap, uses its $5' \rightarrow 3'$ exonuclease activity to remove residual primer bases, and uses its $5' \rightarrow 3'$ polymerase activity to fill in the missing DNA nucleotides using the adjacent $3'\text{-OH}$ group.

  • DNA Ligase: Catalyzes the formation of a phosphodiester bond to seal the single-stranded nick between adjacent synthesized fragments. Requires energy in the form of NAD in bacteria or ATP in eukaryotes.

Plasmid Biology and Replication Mechanisms

• Plasmid Characteristics:

  • Plasmids are autonomous, self-replicating extrachromosomal DNA molecules found in bacteria and lower eukaryotes.

  • Low-Copy-Number Plasmids: Maintained at $1\text{--}2$ copies per cell. Regulated segregation mechanisms guarantee equal distribution into daughter cells during cell division.

  • High-Copy-Number Plasmids: Maintained at high abundance (up to $500$ copies per cell). Replicate continuously and segregate randomly during cell division.

• Modes of Plasmid Replication:

  • Bidirectional Replication: Begins at a designated plasmid origin ($oriV$) and proceeds simultaneously in both directions, identical to chromosomal replication.

  • Unidirectional Rolling-Circle Replication:

  • Initiated by the plasmid-encoded RepA protein, which binds the origin and nicks a single strand of the double-stranded DNA.

  • RepA holds onto the $5'$ end while providing a free $3'\text{-OH}$ group for host DNA polymerase III.

  • Helicase unwinds the intact template strand as Polymerase III extends the $3'$ end, rolling around the plasmid circular template repeatedly.

  • The displaced single strand is subsequently synthesized into double-stranded DNA via RNA priming.

  • Used by many plasmids and bacteriophages.

Transcription Machinery and Dynamics in Bacteria

• RNA Polymerase Architecture:

  • Bacterial RNA Polymerase is a multimeric protein complex responsible for synthesizing RNA from a DNA template.

  • Core Polymerase Complex: Consists of four distinct protein types forming a five-subunit core ($\alpha_1, \alpha_2, \beta, \beta', \omega$).

  • $\alpha_1, \alpha_2$: Subunit assembly and regulatory interaction.

  • $\beta, \beta'$: Catalytic center; binds DNA template and polymerizes ribonucleotides.

  • $\omega$: Plays a structural role in core enzyme assembly and stability.

  • Sigma ($\sigma$) Factor: A distinct regulatory protein that binds the core polymerase to form the RNA Polymerase Holoenzyme. The sigma factor lacks catalytic activity on its own but is required for specific promoter recognition and binding.

• Sigma Factor Diversity:

  • Bacteria produce multiple distinct sigma factors to direct gene transcription under different physiological conditions:

  • $\sigma^{70}$ ($\text{RpoD}$): The primary housekeeping sigma factor responsible for transcribing the vast majority of essential genes during exponential growth.

  • $\sigma^{32}$ / $\sigma^H$ ($\text{RpoH}$): Activated when cells undergo thermal stress, driving expression of the heat-shock protein regulon.

• Transcription Initiation and Promoter Structure:

  • Standard bacterial promoters contain conserved sequence elements located upstream of the transcription start site ($\text{tss}$, designated as $+1$):

  • $-35$ Region: Conserved sequence consensus $\text{TTGACA}$.

  • $-10$ Region (Pribnow Box): Conserved sequence consensus $\text{TATAAT}$.

  • The spacing between the $-35$ and $-10$ elements is typically $17$ base pairs.

  • Initiation Steps:

  1. Holoenzyme ($\text{Core} + \sigma$) scans DNA and binds promoter sequence, forming a closed complex.

  2. RNA Polymerase unwinds $12\text{--}14$ base pairs around the $-10$ region to expose template single-stranded DNA, converting the closed complex into an open complex.

  3. Transcription initiates; once the nascent RNA strand reaches $\sim 10$ nucleotides in length, the sigma factor dissociates, allowing core RNA polymerase to transition to transcription elongation.

• Transcription Elongation:

  • Core RNA Polymerase moves down the DNA template strand, synthesizing complementary RNA in the $5' \rightarrow 3'$ direction.

  • Energy for ribonucleotide addition is derived from the cleavage of pyrophosphate ($\text{PP}_i$) from incoming rNTPs (ATP, CTP, GTP, UTP).

  • The resulting mRNA transcript matches the sequence of the non-template (coding) DNA strand, substituting Uracil for Thymine.

• Transcription Termination Pathways:

  • Rho ($\rho$)-Dependent Termination:

  • Requires the hexameric protein factor Rho ($\rho$).

  • Rho binds to C-rich, unstructured RNA sequences (rut sites) on the synthesized transcript upstream of the polymerase.

  • Rho uses ATP hydrolysis to thread mRNA through its central cavity, tracking along the transcript toward RNA Polymerase. When RNA Polymerase pauses at a termination site, Rho collides with the complex and unwinds the RNA-DNA hybrid helix, releasing the mRNA and dislodging RNA Polymerase.

  • Rho ($\rho$)-Independent Termination:

  • Does not require accessory protein factors.

  • Requires a specific sequence motif on the template strand consisting of inverted GC-rich repeats followed by a string of Adenine ($A$) residues.

  • As the GC-rich sequence is transcribed, it folds into a stable GC-rich hairpin stem-loop structure in the mRNA, causing RNA Polymerase to physically stall.

  • Immediately downstream of the hairpin, a series of Uracil ($U$) residues pair with template Adenine ($A$) residues. The weak hydrogen bonding of $U-A$ base pairs is insufficient to hold the hybrid duplex together, causing the transcript to detach and releasing RNA Polymerase from DNA.

Genetic Code, tRNA Synthetases, and Translational Dynamics

• Properties of the Genetic Code:

  • Written in triplet nucleotide sequences called codons.

  • Total possible codons: $4^3 = 64$ unique codons.

  • Amino Acid Coding: $61$ codons specify amino acids, including the start codon $\text{AUG}$ (which encodes Methionine in eukaryotes / N-formylmethionine in bacteria).

  • Stop Codons: $3$ codons ($\text{UAA}, \text{UAG}, \text{UGA}$) do not encode amino acids and trigger translation termination.

  • Degenerate / Redundant: Multiple codons can encode the same amino acid (e.g., Leucine, Serine, and Arginine are each encoded by six distinct codons).

  • Universal: The genetic code is conserved across virtually all biological domains, from viruses and bacteria to humans.

• tRNA Charging and Aminoacyl-tRNA Synthetases:

  • Transfer RNA (tRNA) molecules act as adaptors, possessing a three-base anticodon loop at one end and a specific amino acid attachment site at the $3'$ acceptor stem.

  • Aminoacyl-tRNA Transferase (Synthetase): Enzymes responsible for charging specific tRNAs with their corresponding amino acid.

  • Reaction requires energy input via ATP hydrolysis:     $\text{Amino Acid} + \text{tRNA} + \text{ATP} \rightarrow \text{Aminoacyl-tRNA} + \text{AMP} + \text{PP}_i$

• Bacterial Ribosome Architecture ($70\text{S}$):

  • Composed of two unequal nucleoprotein subunits:

  • Small Subunit ($30\text{S}$): Contains $16\text{S}$ ribosomal RNA (rRNA) and $21$ ribosomal proteins. Responsible for decoding mRNA.

  • Large Subunit ($50\text{S}$): Contains $23\text{S}$ rRNA, $5\text{S}$ rRNA, and $31$ ribosomal proteins. Catalyzes peptide bond formation.

  • Functional Binding Sites across the intact $70\text{S}$ ribosome:

  • A (Acceptor / Aminoacyl) Site: Binds incoming aminoacyl-tRNA complexes.

  • P (Peptidyl) Site: Holds tRNA linked to the growing polypeptide chain.

  • E (Exit) Site: Holds uncharged tRNA prior to its ejection from the ribosome.

• Translation Initiation:

  1. Initiation factors IF1 and IF3 bind the $30\text{S}$ subunit to prevent premature docking of the $50\text{S}$ subunit.

  2. The $16\text{S}$ rRNA within the $30\text{S}$ subunit binds the mRNA at the Shine-Dalgarno sequence (consensus $5'\text{-AGGAGG-}3'$), positioned $8\text{--}13$ bases upstream of the $\text{AUG}$ start codon.

  3. IF2 bound to GTP recruits the initiator tRNA charged with N-formylmethionine (fMet-tRNA) directly into the P site.

  4. IF1 and IF3 are released, GTP is hydrolyzed by IF2, and the $50\text{S}$ subunit docks onto the $30\text{S}$ subunit to form the functional $70\text{S}$ initiation complex.

• Translation Elongation:

  1. A-Site Entry: Elongation factor EF-Tu-GTP binds charged aminoacyl-tRNA and guides it into the open A site. Upon codon-anticodon pairing, GTP is hydrolyzed and EF-Tu is released.

  2. Peptidyltransferase Activity: The $23\text{S}$ rRNA ribozyme within the $50\text{S}$ subunit catalyzes peptide bond formation, transferring the amino acid or peptide from the P-site tRNA onto the amino acid of the A-site tRNA.

  3. Translocation: Elongation factor EF-G-GTP binds the ribosome. GTP hydrolysis drives ratchet-like movement of the $50\text{S}$ and $30\text{S}$ subunits forward by exactly one codon ($3$ nucleotides).

  4. The uncharged tRNA moves from P site to E site and is ejected. The peptidyl-tRNA moves from A site to P site, leaving the A site empty for the next charged tRNA.

  • Energy Cost: Polymerization requires $3$ high-energy phosphate bonds (GTP/ATP equivalents) per amino acid added.

• Translation Termination:

  1. Movement of the ribosome places a stop codon ($\text{UAA}, \text{UAG}, \text{UGA}$) into the A site.

  2. Release factors RF1 (recognizes $\text{UAA}$ and $\text{UAG}$) or RF2 (recognizes $\text{UAA}$ and $\text{UGA}$) bind the stop codon in the A site.

  3. RF1/RF2 activates peptidyltransferase to hydrolyze the ester bond linking the polypeptide chain to the P-site tRNA, releasing the completed protein.

  4. RF3-GTP triggers the release of RF1/RF2. Ribosome Recycling Factor (RRF) and IF3 dissociate the $70\text{S}$ ribosome into its $30\text{S}$ and $50\text{S}$ subunits, clearing mRNA.

• Coupling of Transcription and Translation in Prokaryotes:

  • Because bacteria lack a nuclear membrane, transcription and translation occur within the same cytoplasmic compartment.

  • Ribosomes bind the Shine-Dalgarno site of an mRNA transcript and begin translation immediately while RNA Polymerase is still synthesizing the downstream sequence.

  • Multiple ribosomes bind simultaneously to a single mRNA, forming a polysome (polyribosome) array, resulting in high rates of protein synthesis from a single gene.

Eukaryotic Gene Expression and Post-Transcriptional Processing

• Key Differences from Prokaryotes:

  • Spatial Partitioning: Transcription occurs inside the membrane-bound nucleus; translation occurs in the cytoplasm.

  • Gene Structure: Eukaryotic genes contain non-coding intervening sequences (introns) interspersed between coding sequences (exons). Bacterial genes lack introns.

  • Operons: Eukaryotes lack polycistronic operons. Most eukaryotic genes are transcribed individually under distinct promoters.

• Post-Transcriptional RNA Processing Steps:

  1. $5'$ Capping: A modified guanine nucleotide ($7\text{-methylguanosine}$) is added in a $5'\text{-to-}5'$ triphosphate linkage ($7\text{-methyl-Gppp}$) to the $5'$ end of nascent pre-mRNA to protect against degradation and promote ribosome binding.

  2. $3'$ Cleavage and Polyadenylation: RNA polymerase transcribes past a cleavage signal sequence ($5'\text{-AAUAAA-}3'$). Specific cleavage factors bind the transcript, cleave it downstream, and Poly(A) Polymerase adds a tail of $100\text{--}250$ Adenine residues (poly(A) tail) to stabilize the mRNA for nuclear export.

  3. RNA Splicing: Spliceosome complexes remove introns and ligate exons together to yield mature mRNA ready for export.

Post-Translational Modifications and Protein Folding

• Covalent Modifications:

  • N-Terminal Cleavage: Removal of N-formylmethionine (fMet) or signal peptides from newly translated proteins.

  • Chemical Addition: Enzymatic covalent addition of functional groups:

  • Phosphorylation (addition of phosphate groups to Ser/Thr/Tyr; alters activation state).

  • Methylation (addition of methyl groups).

  • Acetylation (addition of acetyl groups).

  • Adenylation (addition of AMP moieties).

  • Glycosylation (addition of carbohydrate side chains).

  • Proteolytic Processing: Cleavage of inactive precursor proteins to release active peptide fragments.

• Chaperone-Assisted Protein Folding:

  • While many small proteins fold spontaneously into their native tertiary structures, complex or heat-denatured proteins require chaperones.

  • GroEL-GroES Chaperonin Complex: A barrel-shaped protein complex that captures unfolded proteins inside its central cavity and uses ATP hydrolysis to force correct folding.

  • DnaK-DnaJ-GrpE System: Binds hydrophobic regions of nascent or denatured polypeptide chains to prevent misfolding and aggregation.

Bacterial Transcriptional Regulation and Signaling Pathways

• Environmental Response Mechanisms:

  • Bacteria constantly adapt to environmental changes by adjusting growth rates, metabolic protein production, and motility.

  • Regulation occurs via mechanisms at the transcriptional, translational, and post-translational levels.

• Two-Component Signal Transduction Systems:

  • Primary mechanism for sensing external stimuli:

  1. Sensor Kinase: Transmembrane protein containing an extracellular ligand-binding domain and an intracellular kinase domain. Binding of an environmental signal triggers autophosphorylation at a specific Histidine residue using ATP.

  2. Response Regulator: Cytoplasmic protein that receives the phosphate group on an Aspartate residue from the sensor kinase. Phosphorylation activates the response regulator, allowing it to bind chromosomal operator sequences and alter transcription rates.

• Transcriptional Control by Regulatory Proteins:

  • Activators: Regulatory proteins that bind DNA promoter/operator sequences and recruit RNA Polymerase, directly increasing transcription initiation rates.

  • Repressors: Regulatory proteins that bind DNA operator sequences and block RNA Polymerase access, suppressing gene expression.

• Assaying DNA-Protein Interactions (Gel Mobility Shift Analysis / EMSA):

  • Electrophoretic Mobility Shift Assay (EMSA) measures the physical interaction between regulatory proteins and specific DNA sequences.

  • Radiolabeled DNA probe fragments are incubated with protein extracts and resolved on non-denaturing polyacrylamide gels.

  • Free DNA probes migrate quickly toward the bottom of the gel. Protein-DNA complexes have increased molecular weight and migrate slowly, causing a measurable shift in band mobility.

  • Specificity is verified by adding excess unlabeled competitor DNA (which eliminates the shifted band) or specific antibodies (which cause a supershift).

The E. coli Lac Operon and Catabolite Repression

• Physiology of Lactose Catabolism:

  • Lactose is a disaccharide (milk sugar) that cannot passively cross the inner bacterial membrane.

  • Lactose Permease ($LacY$): Active transport protein that uses the proton motive force (PMF) to symport lactose into the cytoplasm.

  • $\beta$-Galactosidase ($LacZ$): Cytoplasmic enzyme that cleaves lactose into glucose and galactose for entry into glycolysis. (Humans also express $\beta$-galactosidase; deficiency results in lactose intolerance).

• Structural Architecture of the $lac$ Operon:

  • An operon is a cluster of genes under the control of a single promoter, transcribed into a single polycistronic mRNA transcript.

  • $lacZ$: Encodes $\beta$-galactosidase.

  • $lacY$: Encodes lactose permease.

  • $lacA$: Encodes thiogalactoside transacetylase (detoxifies non-metabolizable galactosides).

  • $lacI$: Upstream gene with its own promoter ($P_{lacI}$); encodes the LacI Repressor protein.

• Negative Regulation (Repression vs. Induction):

  • Absence of Lactose: LacI repressor forms a homotetramer and binds tightly to the operator ($lacO$), creating a DNA loop that blocks RNA Polymerase holoenzyme from binding the promoter ($P_{lacZYA}$).

  • Presence of Lactose: $\beta$-galactosidase converts a small fraction of lactose into allolactose (the true inducer). Allolactose binds the LacI repressor protein, inducing a conformational change that drastically reduces LacI affinity for $lacO$. The repressor detaches, allowing transcription.

• Catabolite Repression and Diauxic Growth:

  • Glucose is the energetically preferred carbon source. When glucose and lactose are both present, bacteria catabolize glucose first, repressing the $lac$ operon.

  • Diauxic Growth: Culture growth displays a biphasic curve. Phase 1 represents rapid growth on glucose. Once glucose is exhausted, a lag phase occurs while $lac$ enzymes are synthesized, followed by Phase 2 growth on lactose.

• Glucose Control via PEP-PTS Phosphotransferase System:

  • Glucose transport into the cell uses the phosphoenolpyruvate-dependent phosphotransferase system (PTS).

  • During glucose import, phosphate groups pass sequentially from PEP through enzyme components $\text{EI} \rightarrow \text{HPr} \rightarrow \text{IIA}^{\text{Glc}} \rightarrow \text{IIB} \rightarrow \text{IIC}$ to phosphorylate glucose into glucose-6-phosphate.

  • High Glucose Levels: Unphosphorylated $\text{IIA}^{\text{Glc}}$ accumulates in the cytoplasm.

  • Unphosphorylated $\text{IIA}^{\text{Glc}}$ directly binds and inhibits Adenylate Cyclase, preventing conversion of ATP into cyclic AMP (cAMP). Internal cAMP pool drops.

  • Low Glucose Levels: $\text{IIA}^{\text{Glc}}$ remains phosphorylated.

  • Phosphorylated $\text{IIA}^{\text{Glc}}$ activates Adenylate Cyclase, raising intracellular cAMP levels.

• Positive Regulation via cAMP and CRP:

  • Maximum transcription of the $lac$ operon requires binding of the cAMP Receptor Protein (CRP), also called Catabolite Activator Protein (CAP).

  • When glucose is absent, rising cAMP levels allow formation of cAMP-CRP complexes.

  • cAMP-CRP binds a specific DNA site located upstream of the $lac$ promoter, physically bending DNA and interacting with the $\alpha$ subunit of RNA Polymerase to recruit holoenzyme to the promoter.

• Inducer Exclusion Mechanism:

  • Glucose transport actively blocks the entry of lactose into the cell.

  • Unphosphorylated $IIA^{Glc}$ (present when glucose is high) binds directly to Lactose Permease ($LacY$), uncoupling its activity and preventing lactose transport. This prevents allolactose formation, ensuring the operon remains OFF.

The Trp Operon and Transcriptional Attenuation

• Architecture of the $trp$ Operon:

  • An anabolic operon encoding five structural genes ($trpE, trpD, trpC, trpB, trpA$) required for biosynthesis of the amino acid Tryptophan.

  • Regulated in opposition to catabolic operons: expression is turned OFF when Tryptophan is abundant, and turned ON when Tryptophan is absent.

• Transcriptional Repression (Aporepressor/Holorepressor):

  • Trp Aporepressor ($TrpR$): Inactive repressor protein produced continuously by the cell; cannot bind DNA on its own.

  • Corepressor (Tryptophan): When intracellular tryptophan levels are high, tryptophan binds the Trp aporepressor to form the active Trp Holorepressor.

  • The holorepressor binds the $trp$ operator ($trpO$), blocking RNA Polymerase.

• Mechanism of Attenuation:

  • Attenuation fine-tunes transcription by linking translation speed directly to mRNA transcription termination within the leader region ($trpL$).

  • The $trpL$ leader sequence encodes a short leader peptide containing two adjacent Tryptophan (Trp) codons, followed by four distinct mRNA segments (Regions 1, 2, 3, and 4) capable of forming alternative secondary stem-loop structures.

  • High Tryptophan Levels (Termination):

  1. Abundant charged $\text{tRNA}^{\text{Trp}}$ allows the translating ribosome to translate through the leader peptide quickly, reaching the stop codon.

  2. The ribosome physically covers Regions 1 and 2.

  3. Region 3 base-pairs with Region 4 to form the 3:4 attenuator stem-loop (GC-rich hairpin followed by U-rich tract).

  4. The 3:4 loop acts as a Rho-independent terminator, causing RNA Polymerase to drop off DNA before reaching $trpE$.

  • Low Tryptophan Levels (Transcription Proceeds):

  1. Scarce charged $\text{tRNA}^{\text{Trp}}$ causes the ribosome to stall at the adjacent Trp codons in Region 1.

  2. Stalled ribosome covers Region 1, leaving Region 2 exposed.

  3. Region 2 base-pairs with Region 3 to form the 2:3 anti-attenuator stem-loop.

  4. Formation of the 2:3 stem-loop prevents Region 3 from pairing with Region 4. The 3:4 terminator cannot form, allowing RNA Polymerase to transcribe the full $trpEDCBA$ operon.

Riboswitches and Alternative RNA-Based Regulation

• Riboswitch Mechanisms:

  • A riboswitch is a sensory secondary structure located within the $5'$ untranslated region ($5'$ UTR) of an mRNA molecule.

  • Riboswitches bind specific small-molecule metabolites (e.g., vitamins, amino acids, purines) directly without requiring regulatory proteins.

  • Metabolite binding triggers a conformational shift in the mRNA structure, leading to one of three regulatory outcomes:

  1. Transcription Termination: Direct formation of a stem-loop terminator.

  2. Ribosome Exclusion: Structural masking of the Shine-Dalgarno sequence, preventing translation initiation.

  3. mRNA Degradation: Exposure of cleavage sites for targeted endoribonucleases.

Bacteriophage Lambda Lytic vs. Lysogenic Regulatory Circuits

• Life Cycle Decision Overview:

  • Lytic Cycle: Phage rapidly replicates, packages viral DNA into progeny capsids, and lyses host cell.

  • Lysogenic Cycle: Phage DNA integrates into host genome as a quiescent prophage, replicating passively alongside host division.

• Lambda Regulatory Proteins and Genetic Switch:

  • cI Repressor (Lambda Repressor): Maintains lysogeny. Binds operator site $O_R$, repressing promoter $P_R$ (blocking synthesis of Cro). Binds $O_L$, repressing $P_L$ (blocking downstream lytic genes). Activates its own synthesis via $P_{RM}$.

  • Cro Protein: Drives the lytic cycle. Represses promoter $P_{RM}$ (blocking cI synthesis). Activates promoter $P_L$ and $P_R$, driving expression of lytic structural genes.

  • cII Activator Protein: Critical regulatory protein that activates transcription of cI from promoter $P_{RE}$.

• Environmental Control Factors (Lysis vs. Lysogeny Decision):

  • High Multiplicity of Infection (MOI) or Nutrient Starvation (Stationary Phase):

  • Intracellular host proteases (such as FtsH) are low or inactive.

  • cII protein accumulates without being degraded.

  • Accumulated cII drives high expression of cI repressor.

  • High cI levels shut down lytic promoters, establishing Lysogeny.

  • Low MOI or Rapid Nutrient Growth (Log Phase):

  • Active host proteases rapidly degrade cII.

  • cI repressor cannot accumulate.

  • Cro protein predominates, driving transcription of lytic cascade and leading to Lysis.

Environmental Adaptation and Cell-Density Sensing Pathways

• Heat Shock Response Pathway ($\sigma^H$):

  • At $30^\circ\text{C}$ (Normal Conditions):

  1. $rpoH$ gene is transcribed, but $rpoH$ mRNA secondary structure masks the ribosome-binding site, yielding minimal translation of $\sigma^H$

  2. Any synthesized $\sigma^H$ protein is immediately bound by the chaperone complex DnaK-DnaJ-GrpE and shunted to protease degradation systems.

  • At $42^\circ\text{C}$ (Heat Shock Conditions):

  1. High temperatures melt $rpoH$ mRNA secondary structure, unmasking the Shine-Dalgarno site and increasing translation of $\sigma^H$

  2. Heat denatures native cellular proteins. Denatured unfolded proteins bind DnaK-DnaJ-GrpE chaperones.

  3. DnaK-DnaJ-GrpE chaperones are sequestered away from $\sigma^H$

  4. Freed $\sigma^H$ stabilizes and binds core RNA Polymerase, directing transcription of heat-shock genes (chaperones and proteases).

• Phase Variation via DNA Inversion (Salmonella enterica):

  • Salmonella enterica alternates expression between two distinct flagellar protein subunits (H1 flagellin and H2 flagellin) to evade host immune detection.

  • Mediated by a site-specific recombinase (Hin) acting on an invertible DNA segment containing promoter $P$ flanked by $hixL$ and $hixR$ recombination sites.

  • Orientation 1 (H2 Expressed): The promoter drives transcription of $fljB$ (encoding H2 flagellin) and $fljA$ (encoding a repressor protein that blocks $fliC$ expression).

  • Orientation 2 (H1 Expressed): Hin recombinase flips the promoter sequence. The promoter now points in the opposite direction (OFF). Transcription of $fljB$ and $fljA$ ceases. Absence of FljA repressor allows expression of $fliC$ (encoding H1 flagellin).

• Chemotaxis Signal Transduction Network:

  • Allows motile bacteria to navigate chemical gradients by controlling direction of flagellar rotation:

  • Counterclockwise (CCW) Rotation: Flagella form a smooth bundle, resulting in forward Running.

  • Clockwise (CW) Rotation: Flagellar bundle breaks apart, causing cell Tumbling to reorient.

  • Chemotaxis Pathway Circuitry:

  • MCPs (Methyl-accepting Chemotaxis Proteins): Transmembrane receptors that bind chemical attractants or repellents.

  • CheA Kinase & CheW: MCPs interact with CheW to regulate CheA histidine kinase activity.

  • No Attractant Present: CheA autophosphorylates and transfers phosphate to CheY. CheY-P binds the flagellar motor base, switching rotation to CW (Tumble). CheZ dephosphorylates CheY-P to allow temporary runs.

  • Attractant Present: Attractant binding to MCP inhibits CheA kinase activity. CheY remains unphosphorylated, resulting in prolonged CCW (Smooth Running) toward attractants.

  • Adaptation Mechanism: CheR continuously methylates MCPs, requiring higher attractant concentration to suppress CheA. CheB-P (activated by CheA) demethylates MCPs to reset sensitivity.

• Quorum Sensing and Bioluminescence Regulation:

  • Quorum Sensing: Mechanism by which bacteria monitor population density through cell-cell signaling molecules.

  • First characterized in Vibrio fischeri, a bioluminescent bacterium that forms symbiotic associations inside the light organ of the Hawaiian bobtail squid.

  • Mechanism of $lux$ Operon Activation:

  1. LuxI Synthetase: Synthesizes a small signal molecule, an acyl-homoserine lactone (AHL) autoinducer (AI).

  2. AI freely diffuses out of the cell and accumulates in the environment as cell density increases.

  3. At high population density, extracellular AI reaches a threshold concentration and diffuses back into the cell.

  4. AI binds the transcriptional activator protein LuxR.

  5. LuxR-AI complex binds the promoter of the $luxCDABEG$ operon, activating transcription of luciferase structural genes.

  • Luciferase Reaction:     $\text{FMNH}_2 + \text{O}_2 + \text{RCOH} \rightarrow \text{FMN} + \text{RCOOH} + \text{H}_2\text{O} + \text{Light}$

Mechanisms of Horizontal Gene Transfer and Bacterial Defense

• Discovery of the Transforming Principle:

  • Frederick Griffith (1928): Injected mice with strains of Streptococcus pneumoniae:

  • Living Smooth (S) strain (capsulated, virulent) $\rightarrow$ Mouse died.

  • Living Rough (R) strain (non-capsulated, nonvirulent) $\rightarrow$ Mouse healthy.

  • Heat-killed S strain $\rightarrow$ Mouse healthy.

  • Heat-killed S strain + Living R strain $\rightarrow$ Mouse died; living capsulated S strain bacteria recovered from blood.

  • Conclusion: A chemical substance from dead S cells genetically transformed living R cells into virulent S cells.

• Avery, MacLeod, and McCarty (1944):

  • Fractionated heat-killed S strain cell extracts and treated them with enzymatic degradation assays:

    • Protease treatment (degrades protein) $\rightarrow$ Transformation occurred.

    • RNase treatment (degrades RNA) $\rightarrow$ Transformation occurred.

    • DNase treatment (degrades DNA) $\rightarrow$ Transformation destroyed.

  • Conclusion: Proved conclusively that DNA is the genetic transforming material.

  • Bacterial Transformation Mechanism:

• Competence: State in which a bacterial cell can bind and import exogenous double-stranded DNA fragments from its environment.

  • Natural competence occurs naturally in specific species (Streptococcus, Bacillus, Neisseria).

  • Artificial competence is induced in laboratories via calcium chloride treatment, heat shock, or electroporation.

• Imported DNA fragments integrate into host chromosomes via homologous recombination, generating a partial diploid (merozygote).

  • Bacterial Conjugation Mechanism:

• Transfer of plasmid DNA mediated by direct cell-to-cell contact.

• Mediated by the Fertility ($F$) factor plasmid ($F^+$ donor cell possesses $F$ factor; $F^-$ cell lacks it).

• Conjugation Steps:

  1. $F^+$ cell expresses a specialized sex pilus that attaches to receptor sites on an $F^-$ cell.

  2. Pilus retracts, bringing donor and recipient membranes into close contact.

  3. A single strand of the conjugative plasmid is nicked at origin $oriT$ and transferred into the $F^-$ recipient cell via rolling-circle replication.

  4. Complementary strands are synthesized in both cells. Both cells now contain circular double-stranded $F$ plasmids and become $F^+$.

• High-Frequency Recombination (Hfr) Strains:

  • Occurs when the $F$ factor plasmid integrates directly into the bacterial chromosome via homologous recombination.

  • During conjugation, the integrated $F$ factor attempts to transfer the entire bacterial chromosome into recipient cells.

  • Chromosomal genes adjacent to the integration site are transferred sequentially at high frequency before the conjugation bridge breaks.

  • Bacterial Transduction Mechanisms:

• Generalized Transduction:

  • Mediated by lytic bacteriophages.

  • During viral assembly, host bacterial chromosomal DNA is accidentally packaged into a phage head instead of viral DNA, producing a defective transducing particle (occurs at a frequency of approximately $1 \times 10^{-6}$).

  • When the transducing phage infects a new recipient host, it injects donor bacterial DNA, which recombines into the recipient chromosome.

• Specialized Transduction:

  • Mediated by lysogenic temperate phages (e.g., Phage Lambda).

  • Phage genome integrates at specific site in host chromosome (e.g., between $gal$ and $bio$ loci).

  • Upon induction, aberrant excision of the prophage carries adjacent specific host genes ($gal$ or $bio$) along with viral DNA into newly packaged phage capsids.

  • Bacterial Defense: Restriction-Modification Systems:

• Bacteria protect their host genome from foreign viral or plasmid DNA using restriction-modification systems:

  • Restriction Endonucleases: Cleave incoming unmethylated double-stranded foreign DNA at specific palindromic sequences (e.g., EcoRI cleaves at $5'\text{-GAATTC-}3'$).

  • Site-Specific DNA Methyltransferases: Methylate specific nucleotides within host genomic recognition sequences, protecting host DNA from endonuclease digestion.

  • Diagnostic Differentiation of HGT Mechanisms:

• DNase Sensitivity: Transformation is destroyed by extracellular DNase; Conjugation and Transduction are completely unaffected.

• Physical Barrier Filters ($0.2\,\mu\text{m}$ membrane): Conjugation is blocked by filters preventing direct cell contact; Transformation and Transduction proceed unaffected.

Principles of Chemotherapy and Susceptibility Testing

• Selective Toxicity:

  • An effective antimicrobial drug must selectively kill or inhibit the pathogen without causing toxic side effects in human hosts.

  • Achieved by targeting physiological pathways present in microbes that are absent or significantly different in human cells:

  • Peptidoglycan cell wall biosynthesis.

  • Structural differences between bacterial $70\text{S}$ ribosomes and eukaryotic $80\text{S}$ ribosomes.

  • Folic acid metabolic pathways.

  • High concentrations of certain antibiotics can cause host toxicity (e.g., Chloramphenicol disrupts human mitochondrial ribosomes, causing aplastic anemia).

• Spectrum of Activity:

  • Broad-Spectrum Antibiotics: Active against a wide variety of Gram-positive and Gram-negative bacterial species.

  • Narrow-Spectrum Antibiotics: Active against specific groups or single species of organisms.

• Antimicrobial Susceptibility Assays:

  • Kirby-Bauer Disk Diffusion Assay: Standardized agar diffusion assay using filter discs impregnated with known drug amounts. Measures clear zones of inhibition around discs on lawn cultures.

  • E-Test (Epsilometer Test): Uses plastic strips containing a continuous exponential concentration gradient of antibiotic to directly read the Minimum Inhibitory Concentration (MIC) at the ellipse edge.

  • Tube Dilution Assay:

  • Serial two-fold dilutions of antibiotic in broth inoculated with standardized bacterial suspensions.

  • Minimum Inhibitory Concentration (MIC): Lowest concentration of drug that prevents visible bacterial turbidity.

  • Tubes showing no growth are subcultured onto drug-free media. The lowest concentration yielding no colonies is the Minimum Bactericidal Concentration (MBC).

Mechanisms of Action for Antibacterial Therapeutics

• Membrane-Active Disruption Agents:

  • Detergent-like molecules that bind bacterial cell membranes:

  • Polymyxins: Cyclic peptides with hydrophobic tails that bind lipid A and phospholipids, disrupting Gram-negative outer and inner membranes.

  • Gramicidins: Channel-forming peptide ionophores that compromise membrane potential.

• Inhibitors of DNA Topology and Replication:

  • Topoisomerase / DNA Gyrase Inhibitors:

  • Nalidixic Acid: Binds GyrA subunit, blocking DNA strand nicking and rejoining.

  • Novobiocin: Binds GyrB subunit, blocking ATP hydrolysis.

  • Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin): Stabilize covalent DNA-Gyrase complexes with broken strands, halting replication forks and causing cell lysis.

• Inhibitors of Transcription:

  • Actinomycin D: Non-specific DNA intercalating agent that blocks RNA polymerase movement. Highly toxic to host cells; used primarily as a laboratory reagent.

  • Rifampin: Binds specifically to the $\beta$ subunit of bacterial RNA Polymerase, blocking mRNA chain elongation after initiation. Primary drug for treating Mycobacterium tuberculosis.

• Inhibitors of Protein Synthesis ($30\text{S}$ and $50\text{S}$ Ribosomal Subunits):

  • $30\text{S}$ Subunit Targets:

  • Aminoglycosides (Streptomycin, Neomycin, Gentamicin): Bind $16\text{S}$ rRNA of $30\text{S}$ subunit, distorting tRNA docking sites, causing misreading of genetic code and premature translation termination (bactericidal).

  • Tetracyclines: Reversibly bind $30\text{S}$ subunit, physically blocking aminoacyl-tRNA entry into the A site (bacteriostatic).

  • $50\text{S}$ Subunit Targets:

  • Chloramphenicol: Binds $50\text{S}$ subunit and directly inhibits peptidyltransferase activity, blocking peptide bond formation.

  • Macrolides (Erythromycin, Azithromycin), Lincosamides (Clindamycin), and Streptogramins (Virginiamycin): Bind $50\text{S}$ rRNA near the P site, physically blocking ribosome translocation along mRNA.

  • Initiation Complex Inhibitors:

  • Oxazolidinones (Linezolid): Bind $50\text{S}$ subunit, preventing assembly of functional $70\text{S}$ initiation complexes.

• Inhibitors of Metabolic Pathways (Folic Acid Synthesis):

  • Sulfa Drugs (Sulfanilamide, Prontosil) & Trimethoprim:

  • Structural analogs of $p$-aminobenzoic acid (PABA).

  • Competitively inhibit enzymes in the biosynthesis pathway of tetrahydrofolic acid (THFA).

  • THFA is an essential single-carbon carrier required for purine, pyrimidine, and amino acid synthesis. Mammals lack these synthetic enzymes and absorb folate from dietary sources, rendering sulfa drugs selectively toxic.

• Inhibitors of Peptidoglycan Cell Wall Biosynthesis:

  • Early Monomer Synthesis Inhibitors:

  • Fosfomycin: Phosphoenolpyruvate (PEP) structural analog; inhibits MurA enzyme.

  • D-Cycloserine: Structural analog of D-alanine; inhibits D-alanyl-D-alanine synthetase, preventing assembly of pentapeptide monomers.

  • Lipid Carrier Cycle Inhibitors:

  • Bacitracin: Blocks pyrophosphatase dephosphorylation of bactoprenol lipid carriers, preventing recycled carriers from transporting new peptidoglycan monomers across the membrane.

  • Vancomycin: Large glycopeptide antibiotic that binds directly to the D-Ala-D-Ala terminus of peptidoglycan pentapeptides, sterically blocking transglycosylation and transpeptidation reactions.

  • $\beta$-Lactam Antibiotics (Penicillins, Cephalosporins, Carbapenems, Monobactams):

  • Structural analogs of the D-Ala-D-Ala peptide terminus.

  • Covalently react with active-site Serine residues of Transpeptidase enzymes (Penicillin-Binding Proteins, PBPs), preventing peptide cross-linking between adjacent glycan chains. The un-crosslinked cell wall becomes weak, resulting in osmotic lysis.

Antifungal and Antiviral Chemotherapeutics

• Antifungal Therapeutics:

  • Fungi are eukaryotic organisms, making selective toxicity more difficult to achieve:

  • Polyene Membrane Agents (Nystatin, Amphotericin B): Bind specifically to ergosterol (the primary fungal membrane sterol absent in human cells), organizing into lethal membrane pores.

  • Imidazoles / Azoles (Miconazole, Ketoconazole): Inhibit enzymes involved in fungal ergosterol biosynthesis.

  • Flucytosine: Fluorinated pyrimidine analog converted inside fungal cells into toxic metabolites that inhibit RNA and DNA synthesis.

  • Griseofulvin: Selectively accumulates in keratinized tissue and disrupts fungal mitotic spindle microtubule assembly; highly effective against dermatophytes (ringworm).

• Antiviral Therapeutics:

  • Viruses utilize host cell machinery, complicating selective toxicity:

  • Influenza Uncoating Inhibitors (Amantadine): Blocks viral M2 membrane protein ion channels, preventing viral uncoating in endosomes.

  • Nucleoside Analogs (Acyclovir): Guanosine structural analog activated specifically by herpesvirus thymidine kinase. Incorporates into viral DNA as an obligate chain terminator.

  • Broad-Spectrum Nucleoside Analogs (Ribavirin): Purine analog that impairs viral RNA synthesis.

  • Anti-HIV Therapies:

    • Reverse Transcriptase Inhibitors: Nucleoside RT inhibitors (e.g., AZT) and non-nucleoside RT inhibitors (e.g., Delavirdine, Nevirapine).

    • Protease Inhibitors (Indinavir, Nelfinavir, Ritonavir): Block viral protease maturation cleavage of gag-pol polyproteins.

  • HIV Resistance Selection: Viral Reverse Transcriptase exhibits high mutation error rates ($1 \times 10^{-4}$ errors/bp). Drug therapy selects for pre-existing resistant viral mutants, requiring combination therapy regimens.

Mechanisms of Antibiotic Resistance and Mitigation Strategies

• Four Primary Biochemical Mechanisms of Bacterial Resistance:

  1. Target Modification: Mutations alter target binding sites so antibiotics no longer bind (e.g., point mutations in ribosomal proteins confer resistance to streptomycin; altered PBPs confer resistance to $\beta$-lactams).

  2. Drug Destruction / Inactivation: Enzymes degrade the drug structure before it reaches its site of action (e.g., $\beta$-lactamase enzymes hydrolyze $\beta$-lactam rings, inactivating penicillins).

  3. Enzymatic Group Addition / Modification: Specific transferase enzymes attach modifying functional groups (acetyl, phosphate, or adenylate) to antibiotics, rendering them inactive (e.g., aminoglycoside-modifying enzymes).

  4. Active Efflux Pumps: Efflux pump assemblies actively transport antibiotics out of the cytoplasm and periplasm back into the extracellular environment (e.g., multidrug exporters composed of a transporter, accessory protein, and outer membrane channel).

• Evolution and Acquisition of Resistance:

  • De Novo Resistance: Develops via spontaneous chromosomal mutations, gene duplication events, and selective pressure.

  • Horizontal Gene Transfer Acquisition: Rapid dissemination of resistance genes via Conjugation (R-plasmids), Transduction, and Transformation.

  • Integrons: Specialized genetic elements containing site-specific recombination systems capable of capturing and expressing multiple antibiotic resistance gene cassettes simultaneously.

• Clinical Mitigation Strategies:

  • Co-administration of Inhibitors: Combining antibiotics with enzyme inhibitors acting as decoy targets (e.g., Augmentin combines Amoxicillin with Clavulanic acid, a $\beta$-lactamase inhibitor).

  • Chemical Modification: Synthesizing derivative molecules with bulky chemical side-chains that sterically hinder access of bacterial modifying enzymes.

  • Chimeric / Linked Antibiotics: Chemically linking two distinct antibiotic classes into single molecules with dual targets.